0.33
4.30%
0.0136
Virpax Pharmaceuticals Inc Azioni (VRPX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
29.50%
3.3025
|
4.6841 | 6.1151 | 3.2395 | 1.6511 |
Operating Income/Loss |
29.50%
-3.3025
|
-4.6841 | -6.1151 | -3.2395 | -1.6511 |
Nonoperating Income/Loss |
0.082
|
- | - | - | - |
Income/Loss From Continuing Operations Before Tax |
29.40%
-3.2204
|
-4.5617 | -5.9945 | -3.1128 | -1.5205 |
Income/Loss From Continuing Operations After Tax |
29.40%
-3.2204
|
-4.5617 | -5.9945 | -3.1128 | -1.5205 |
Net Income/Loss
|
29.40%
-3.2204
|
-4.5617 | -5.9945 | -3.1128 | -1.5205 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
111.11%
1.1712
|
-10.54 | 11.71 | 11.71 | 11.71 |
Diluted Average Shares |
111.11%
1.1712
|
-10.54 | 11.71 | 11.71 | 11.71 |
Basic Earnings Per Share |
77.20%
-2.75
|
-12.06 | -0.51 | -0.27 | -0.13 |
Diluted Earnings Per Share |
77.20%
-2.75
|
-12.06 | -0.51 | -0.27 | -0.13 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):